Wells Fargo’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-101
| Closed | – | – | 6786 |
|
|
2018
Q4 | $0 | Sell |
101
-75
| -43% | -$47 | ﹤0.01% | 6878 |
|
|
2018
Q3 | $0 | Hold |
176
| – | – | ﹤0.01% | 6804 |
|
|
2018
Q2 | $0 | Hold |
176
| – | – | ﹤0.01% | 6850 |
|
|
2018
Q1 | $0 | Hold |
176
| – | – | ﹤0.01% | 6796 |
|
|
2017
Q4 | $0 | Hold |
176
| – | – | ﹤0.01% | 6776 |
|
|
2017
Q3 | $1K | Hold |
176
| – | – | ﹤0.01% | 6274 |
|
|
2017
Q2 | $1K | Hold |
176
| – | – | ﹤0.01% | 6172 |
|
|
2017
Q1 | $1K | Sell |
176
-201
| -53% | -$631 | ﹤0.01% | 6266 |
|
|
2016
Q4 | $1K | Sell |
377
-98
| -21% | -$355 | ﹤0.01% | 6221 |
|
|
2016
Q3 | $3K | Hold |
475
| – | – | ﹤0.01% | 6025 |
|
|
2016
Q2 | $2K | Sell |
475
-1,262
| -73% | -$8.24K | ﹤0.01% | 5979 |
|
|
2016
Q1 | $18K | Buy |
1,737
+349
| +25% | +$6.94K | ﹤0.01% | 5549 |
|
|
2015
Q4 | $41K | Sell |
1,388
-957
| -41% | -$28.9K | ﹤0.01% | 5362 |
|
|
2015
Q3 | $74K | Sell |
2,345
-54,655
| -96% | -$2.61M | ﹤0.01% | 5088 |
|
|
2015
Q2 | $3.37M | Buy |
57,000
+12,480
| +28% | +$880K | ﹤0.01% | 2702 |
|
|
2015
Q1 | $4.76M | Buy |
44,520
+6,828
| +18% | +$651K | ﹤0.01% | 2411 |
|
|
2014
Q4 | $3.54M | Buy |
37,692
+37,539
| +24,535% | +$3.58M | ﹤0.01% | 2592 |
|
|
2014
Q3 | $12K | Sell |
153
-284
| -65% | -$22.4K | ﹤0.01% | 5523 |
|
|
2014
Q2 | $39K | Buy |
+437
| New | +$26.8K | ﹤0.01% | 5073 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 6246 |
|
|
2013
Q4 | – | Sell |
-100
| Closed | -$3K | – | 6097 |
|
|
2013
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 5414 |
|
|
2013
Q2 | $4K | Buy |
+100
| New | +$3.75K | ﹤0.01% | 5275 |
|
Wells Fargo's PTX Position: Q1 2019 in Review
Wells Fargo sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 101 shares.
Wells Fargo first reported a position in PTX in Q2 2013 and held it in 21 quarters. The position peaked at $4.76M in Q1 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Wells Fargo reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Wells Fargo sold 101 Pernix Therapeutics Holdings, Inc. shares in Q1 2019.
- Wells Fargo first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 21 quarters.
- Wells Fargo's Pernix Therapeutics Holdings, Inc. position peaked at $4.76M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Wells Fargo's 13F filing for Q1 2019, filed 10 May 2019.